1 / 1

Growing at an annualized rate of over 16.5%, By Roots Analysis

The approval of KYMIRAHu00ae, YESCARTAu00ae, Alofiselu00ae and Zyntelgou00ae has increased the interest of pharma stakeholders in cell therapies; further, owing to the technical challenges in this field, outsourcing manufacturing operations has become a necessity<br><br>Roots Analysis has announced the addition of u201cCell Therapy Manufacturing Market (3rd Edition), 2019 - 2030u201d <br>

kevin987
Download Presentation

Growing at an annualized rate of over 16.5%, By Roots Analysis

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

    More Related